Tavilermide Ophthalmic Solution for the Treatment of Dry Eye

NCT03925727 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

623

Enrollment

INDUSTRY

Sponsor class

Conditions

Keratoconjunctivitis Sicca
Dry Eye

Interventions

DRUG: Tavilermide ophthalmic solution
OTHER: Placebo

Sponsor

Mimetogen Pharmaceuticals USA, Inc.